Cell-ebrating Success: Ilan Sobel Blends Science and Strategy to Scale-up BioHarvest
What if you could grow health-boosting compounds—not in fields, but in bioreactors—using the power of plant cells? In this episode, Karl and Erum sit down with Ilan Sobel, CEO of BioHarvest, to explore how the company is reshaping biotech, nutraceuticals, and biomanufacturing. From leveraging botanical synthesis to create highly bioavailable compounds like piceid resveratrol, to scaling sustainable DTC operations that rival software margins, Ilan reveals how BioHarvest is closing the gap between nature, science, and commerce. Hear how this Coca-Cola veteran is building a biological infrastructure poised to disrupt pharma, food, and beyond—one cell at a time.
Chapters:
00:00:21 - $9 Trillion Vanishes: Markets, Mayhem, and Monday Mood
00:00:36 - Brooklyn Birthdays, Bio Buzz & Citizen Scientists Unite
00:02:24 - Tariffs, Pharma, and the Future of Drug Supply Chains
00:04:20 - Reddit Rabbit Holes and Underrated Science That Could Change Everything
00:06:49 - Pharma’s Dirty Secret: Why Cures Don’t Always Win
00:09:39 - Meet Ilan Sobel: From Coca-Cola Exec to Biotech World-Changer
00:19:13 - What the Heck Is Botanical Synthesis? (And Why It’s a Game-Changer)
00:26:46 - Tiny Footprint, Massive Impact: Economics That Would Make Silicon Valley Jealous
00:29:02 - How a Grape Cell Became the King of Blood Flow Supplements
00:37:32 - The Secret Sauce Behind Supplements That Actually Work
00:38:55 - How BioHarvest Orchestrated a Biotech Masterpiece
00:40:20 - From Plant Cells to Profit: Scaling Biotech Like a Pro
00:43:10 - Open Sourcing the Future: CDMO Deals with Global Impact
00:57:39 - What’s Next for BioHarvest? Legacy, Longevity, and Global Scale
